20 Companies! Summary of 2024 Financial Performance by Global Chemical Giants!

Celanese On February 18, Celanese—a global chemical and specialty materials company—reported full-year 2024 net sales of $10.3 billion, down 6% year-on-year. This decline was primarily driven by persistently weak global demand across key end markets—including automotive, paints and coatings, construction, and industrial sectors—posing headwinds throughout the year. For 2024, the company reported a consolidated operating loss of $697 million; adjusted EBIT was $1.6 billion (down 6% year-on-year); and operating EBITDA stood at $2.4 billion. Corresponding margins were (7%) for operating margin, 16% for adjusted EBIT margin, and 23% for EBITDA margin. Additionally, Celanese announced its intention to cease production and shut down its Mylar specialty film manufacturing business in Luxembourg—a 50/50 joint venture with Teijin. This move aligns with the company’s core principle of exiting high-cost facilities. Lanxess On January 20, Lanxess issued a preliminary earnings announcement, forecasting Q4 2024 EBITDA of approximately €159 million—22% above the current market consensus (VARA) of €130 million. Accordingly, full-year 2024 EBITDA before non-recurring items is expected to reach approximately €614 million—up roughly 20% year-on-year—and at the upper end of the previously guided growth range of 10–20%. The strong Q4 performance was primarily driven by better-than-expected December sales, particularly due to customer pre-purchasing. This advance-sales effect occurred mainly in the U.S., especially for products from Lanxess’s Specialty Additives and Consumer Protection divisions. Huntsman On February 17, Huntsman Corporation released its 2024 financial results: full-year revenue totaled approximately $6.0 billion, with a net loss of $189 million. In Q4 2024 alone, revenue amounted to $1.452 billion, while net loss attributable to Huntsman was $141 million; adjusted net loss attributable to Huntsman was $43 million, and adjusted EBITDA stood at $71 million. Huntsman’s quarterly results for the first three quarters of 2024 were as follows: Q3 revenue was $1.54 billion with a net loss of $33 million; Q2 revenue was $1.574 billion with net income of $22 million; and Q1 revenue was $1.47 billion with a net loss of $37 million. Syensqo On February 27, Syensqo published its 2024 financial results: net sales totaled €6.6 billion, reflecting an organic decline of 3% year-on-year—primarily attributable to price reductions (−4%). EBITDA amounted to €1.4 billion, in line with expectations. In Q4 2024 specifically, net sales reached €1.6 billion, representing an organic increase of 2% year-on-year—driven mainly by volume growth (+3%). EBITDA for the quarter was €298 million, up 5% organically year-on-year, with contributions from both the Materials and Consumer & Resources businesses. Furthermore, in 2025, Syensqo will continue evaluating various options to accelerate value creation—including asset divestitures—to become a more focused specialty chemicals company. Building on the already-decided divestiture of its oil & gas business, Syensqo plans to adopt the same approach for its Fragrance & Functional Chemicals business.

Q1 2024 Financial Performance Review of Global Chemical Giants (North America Edition)

Original link: Q1 2024 Financial Performance Review of Global Chemical Giants (North America Edition) In Q1 2024, several major chemical companies faced challenges in both revenue and profitability. Dow, Nutrien, Corteva, Mosaic, Eastman, Albemarle, and Chemours all reported year-on-year declines in net sales—indicating weakening market demand. Below is a ranking of these chemical enterprises by revenue: ● The North American chemical industry confronted numerous challenges at the start of 2024. Company performances reflect differing capabilities in navigating economic volatility, managing costs, and adapting to market conditions. As data from this quarter emerges, the industry may seek new strategies to strengthen financial resilience and prepare for future uncertainties.

Chemours Reports Q1 Loss of $29 Million Amid Profitability Concerns

May 7, 2026

Chemours reported a Q1 2026 net loss of $29 million on $1.4 billion revenue, extending its 12-month net loss to $410 million. Investors remain concerned over slowing growth and margin pressures despite steady top-line figures.

Simply Wall Street

2026-05-06

The Chemours Company Posts Q1 Adjusted EPS of $0.05, Beating FactSet Estimate

2026-05-06

Chemours Reports First Quarter Results

2026-05-06

Chemours Reports Strong Q1 2026 Earnings, Exceeds Expectations

2026-05-06

Earnings Call Transcript: Chemours Co Q1 2026 Beats EPS Forecast, Stock Falls

2026-05-06

Chemours Announces Second Quarter Dividend